Immunotherapeutic nitriles
US5728845A · kind A · utility
58Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 29, 1995 |
| Grant date | Mar 17, 1998 |
| Priority date | — |
| Expiry date | Aug 29, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/46
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel nitriles are inhibitors of tumor necrosis factor .alpha. and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory conditions. A typical embodiment is 3-Phthalimido-3-(3,4-dimethoxyphenyl)propionitrile.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.